Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Capital Expenditures (2022 - 2023)

Historic Capital Expenditures for Bluejay Diagnostics (BJDX) over the last 2 years, with Q4 2023 value amounting to $87894.0.

  • Bluejay Diagnostics' Capital Expenditures fell 6310.18% to $87894.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $704166.0, marking a year-over-year decrease of 4128.38%. This contributed to the annual value of $306783.0 for FY2024, which is 5643.31% down from last year.
  • Per Bluejay Diagnostics' latest filing, its Capital Expenditures stood at $87894.0 for Q4 2023, which was down 6310.18% from $74498.0 recorded in Q3 2023.
  • In the past 5 years, Bluejay Diagnostics' Capital Expenditures registered a high of $791464.0 during Q3 2022, and its lowest value of $46346.0 during Q1 2022.